Skip to main content
Top
Published in: Journal of General Internal Medicine 5/2009

01-05-2009 | Original Article

Can Improved Prescription Medication Labeling Influence Adherence to Chronic Medications? An Evaluation of the Target Pharmacy Label

Authors: William H. Shrank, MD, MSHS, Patrick P. Gleason, Pharm. D., Claire Canning, MA, Carol Walters, MBA, Alan H. Heaton, Pharm. D., Saira Jan, Pharm. D., Amanda Patrick, MS, M. Alan Brookhart, PhD, Sebastian Schneeweiss, MD ScD, Daniel H. Solomon, MD MPH, Jerry Avorn, MD, Niteesh K. Choudhry, MD PhD

Published in: Journal of General Internal Medicine | Issue 5/2009

Login to get access

Abstract

BACKGROUND

Prescription medication labels contain valuable health information, and better labels may enhance patient adherence to chronic medications. A new prescription medication labeling system was implemented by Target pharmacies in May 2005 and aimed to improve readability and understanding.

OBJECTIVE

We evaluated whether the new Target label influenced patient medication adherence.

DESIGN AND PATIENTS

Using claims from two large health plans, we identified patients with one of nine chronic diseases who filled prescriptions at Target pharmacies and a matched sample who filled prescriptions at other community pharmacies.

MEASUREMENTS

We stratified our cohort into new and prevalent medication users and evaluated the impact of the Target label on medication adherence. We used linear regression and segmented linear regression to evaluate the new-user and prevalent-user analyses, respectively.

RESULTS

Our sample included 23,745 Target users and 162,368 matched non-Target pharmacy users. We found no significant change in adherence between new users of medications at Target or other community pharmacies (p = 0.644) after implementing the new label. In prevalent users, we found a 0.0069 percent reduction in level of adherence (95% CI −0.0138-0.0; p < 0.001) and a 0.0007 percent increase in the slope in Target users (the monthly rate of change of adherence) after implementation of the new label (95% CI 0.0001–0.0013; p = 0.001).

CONCLUSIONS

We found no changes in adherence of chronic medication in new users, and small and likely clinically unimportant changes in prevalent users after implementation of the new label. While adherence may not be improved with better labeling, evaluation of the effect of labeling on safety and adverse effects is needed.
Appendix
Available only for authorised users
Literature
2.
go back to reference Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002;288(4):455–61.PubMedCrossRef Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002;288(4):455–61.PubMedCrossRef
3.
go back to reference Avorn J, Monette J, Lacour A, Bohn RL, Monane M, Mogun H, LeLorier J. Persistence of use of lipid-lowering medications: a cross-national study. JAMA. 1998;279(18):1458–62.PubMedCrossRef Avorn J, Monette J, Lacour A, Bohn RL, Monane M, Mogun H, LeLorier J. Persistence of use of lipid-lowering medications: a cross-national study. JAMA. 1998;279(18):1458–62.PubMedCrossRef
4.
go back to reference Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836–41.PubMedCrossRef Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836–41.PubMedCrossRef
6.
go back to reference Mehta S, Moore RD, Graham NM. Potential factors affecting adherence with HIV therapy. AIDS. 1997;11(14):1665–70.PubMedCrossRef Mehta S, Moore RD, Graham NM. Potential factors affecting adherence with HIV therapy. AIDS. 1997;11(14):1665–70.PubMedCrossRef
7.
go back to reference Isaac LM, Tamblyn RM. Compliance and cognitive function: a methodological approach to measuring unintentional errors in medication compliance in the elderly. McGill-Calgary Drug Research Team. Gerontologist. 1993;33(6):772–81.PubMed Isaac LM, Tamblyn RM. Compliance and cognitive function: a methodological approach to measuring unintentional errors in medication compliance in the elderly. McGill-Calgary Drug Research Team. Gerontologist. 1993;33(6):772–81.PubMed
8.
go back to reference Tarn DM, Heritage J, Paterniti DA, Hays RD, Kravitz RL, Wenger NS. Physician communication when prescribing new medications. Arch Intern Med. 2006;166(17):1855–62.PubMedCrossRef Tarn DM, Heritage J, Paterniti DA, Hays RD, Kravitz RL, Wenger NS. Physician communication when prescribing new medications. Arch Intern Med. 2006;166(17):1855–62.PubMedCrossRef
9.
go back to reference Svarstad BL, Bultman DC, Mount JK. Patient counseling provided in community pharmacies: effects of state regulation, pharmacist age, and busyness. J Am Pharm Assoc (Wash DC). 2004;44(1):22–9. Svarstad BL, Bultman DC, Mount JK. Patient counseling provided in community pharmacies: effects of state regulation, pharmacist age, and busyness. J Am Pharm Assoc (Wash DC). 2004;44(1):22–9.
10.
go back to reference Fletcher SW, Fletcher RH, Thomas DC, et al. Patients’ understanding of prescribed drugs. J Community Health. 1979;4(3):183–9.PubMedCrossRef Fletcher SW, Fletcher RH, Thomas DC, et al. Patients’ understanding of prescribed drugs. J Community Health. 1979;4(3):183–9.PubMedCrossRef
11.
go back to reference Shrank WH, Avorn J. Educating patients about their medications: the limitations and potential of written drug information. Health Affairs. 2007;26(3):731–40.PubMedCrossRef Shrank WH, Avorn J. Educating patients about their medications: the limitations and potential of written drug information. Health Affairs. 2007;26(3):731–40.PubMedCrossRef
12.
go back to reference Davis TC, Wolf MS, Bass PF 3rd, Thompson JA, Tilson HH, Neuberger M, Parker RM. Literacy and misunderstanding prescription drug labels. Ann Intern Med. 2006;145(12):887–94.PubMed Davis TC, Wolf MS, Bass PF 3rd, Thompson JA, Tilson HH, Neuberger M, Parker RM. Literacy and misunderstanding prescription drug labels. Ann Intern Med. 2006;145(12):887–94.PubMed
13.
go back to reference Davis TC, Wolf MS, Bass PF 3rd, Middlebrooks M, Kennen E, Baker DW, Bennett CL, Durazo-Arvizu R, Bocchini A, Savory S, Parker RM. Low literacy impairs comprehension of prescription drug warning labels. J Gen Intern Med. 2006;21(8):847–51.PubMedCrossRef Davis TC, Wolf MS, Bass PF 3rd, Middlebrooks M, Kennen E, Baker DW, Bennett CL, Durazo-Arvizu R, Bocchini A, Savory S, Parker RM. Low literacy impairs comprehension of prescription drug warning labels. J Gen Intern Med. 2006;21(8):847–51.PubMedCrossRef
14.
go back to reference Shrank WH, Agnew-Blais J, Choudhry NK, Wolf MS, Kesselheim A, Avorn J, Shekelle P. The variability and quality of medication container labels. Arch Intern Med. 2007;167(16):1760–5.PubMedCrossRef Shrank WH, Agnew-Blais J, Choudhry NK, Wolf MS, Kesselheim A, Avorn J, Shekelle P. The variability and quality of medication container labels. Arch Intern Med. 2007;167(16):1760–5.PubMedCrossRef
15.
go back to reference Haynes RB, McDonald H, Garg AX. Interventions for helping patients to follow prescriptions for medications. Oxford, England: Cochrane library, Update software; 2002; issue 2. Haynes RB, McDonald H, Garg AX. Interventions for helping patients to follow prescriptions for medications. Oxford, England: Cochrane library, Update software; 2002; issue 2.
16.
go back to reference Shrank W, Avorn J, Rolón C, Shekelle P. The Effect of the Content and Format of Prescription Drug Labels on Readability, Understanding and Medication Use: a Systematic Review. Annals of Pharmacotherapy. 2007;41(5):783–801.PubMedCrossRef Shrank W, Avorn J, Rolón C, Shekelle P. The Effect of the Content and Format of Prescription Drug Labels on Readability, Understanding and Medication Use: a Systematic Review. Annals of Pharmacotherapy. 2007;41(5):783–801.PubMedCrossRef
18.
go back to reference Samet JH, Libman H, Steger KA, Dhawan RK, Chen J, Shevitz AH, Dewees-Dunk R, Levenson S, Kufe D, Craven DE. Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: a cross-sectional study in a municipal hospital clinic. Am J Med. 1992;92(5):495–502.PubMedCrossRef Samet JH, Libman H, Steger KA, Dhawan RK, Chen J, Shevitz AH, Dewees-Dunk R, Levenson S, Kufe D, Craven DE. Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: a cross-sectional study in a municipal hospital clinic. Am J Med. 1992;92(5):495–502.PubMedCrossRef
19.
go back to reference Isaac LM, Tamblyn RM. Compliance and cognitive function: a methodological approach to measuring unintentional errors in medication compliance in the elderly. McGill-Calgary Drug Research Team. Gerontologist. 1993;33(6):772–81.PubMed Isaac LM, Tamblyn RM. Compliance and cognitive function: a methodological approach to measuring unintentional errors in medication compliance in the elderly. McGill-Calgary Drug Research Team. Gerontologist. 1993;33(6):772–81.PubMed
20.
go back to reference Gazmararian JA, Kripalani S, Miller MJ, Echt KV, Ren J, Rask K. Factors associated with medication refill adherence in cardiovascular-related diseases: a focus on health literacy. J Gen Intern Med. 2006;21(12):1215–21.PubMedCrossRef Gazmararian JA, Kripalani S, Miller MJ, Echt KV, Ren J, Rask K. Factors associated with medication refill adherence in cardiovascular-related diseases: a focus on health literacy. J Gen Intern Med. 2006;21(12):1215–21.PubMedCrossRef
21.
go back to reference Halpern MT, Khan ZM, Schmier JK, Burnier M, Caro JJ, Cramer J, Daley WL, Gurwitz J, Hollenberg NK. Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data. Hypertension. 2006;47(6):1039–48.PubMedCrossRef Halpern MT, Khan ZM, Schmier JK, Burnier M, Caro JJ, Cramer J, Daley WL, Gurwitz J, Hollenberg NK. Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data. Hypertension. 2006;47(6):1039–48.PubMedCrossRef
22.
go back to reference Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;(42):121–30. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;(42):121–30.
23.
go back to reference DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200–9.PubMedCrossRef DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200–9.PubMedCrossRef
24.
go back to reference Kripalani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med. 2007;167(6):540–50.PubMedCrossRef Kripalani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med. 2007;167(6):540–50.PubMedCrossRef
25.
go back to reference Shrank WH, Asch SM, Adams J, Setodji C, Kerr EA, Keesey J, Malik S, McGlynn EA. The Quality of Pharmacologic Care for Adults in the United States. Medical Care. 2006;44(10):936–45.PubMedCrossRef Shrank WH, Asch SM, Adams J, Setodji C, Kerr EA, Keesey J, Malik S, McGlynn EA. The Quality of Pharmacologic Care for Adults in the United States. Medical Care. 2006;44(10):936–45.PubMedCrossRef
26.
go back to reference Higashi T, Shekelle PG, Solomon DH, Knight EL, Roth C, Chang JT, Kamberg CJ, MacLean CH, Young RT, Adams J, Reuben DB, Avorn J, Wenger NS. The quality of pharmacologic care for vulnerable older patients. Ann Intern Med. 2004;140(9):714–20.PubMed Higashi T, Shekelle PG, Solomon DH, Knight EL, Roth C, Chang JT, Kamberg CJ, MacLean CH, Young RT, Adams J, Reuben DB, Avorn J, Wenger NS. The quality of pharmacologic care for vulnerable older patients. Ann Intern Med. 2004;140(9):714–20.PubMed
27.
go back to reference Choudhry NK, Anderson G, Laupacis A, Ross-Degnan D, Normand SL, Soumerai SB. The impact of adverse events on warfarin prescribing in atrial fibrillation: a matched-pair analysis. BMJ. 2006;332:141–5.PubMedCrossRef Choudhry NK, Anderson G, Laupacis A, Ross-Degnan D, Normand SL, Soumerai SB. The impact of adverse events on warfarin prescribing in atrial fibrillation: a matched-pair analysis. BMJ. 2006;332:141–5.PubMedCrossRef
28.
go back to reference Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50(1):105–16.PubMedCrossRef Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50(1):105–16.PubMedCrossRef
Metadata
Title
Can Improved Prescription Medication Labeling Influence Adherence to Chronic Medications? An Evaluation of the Target Pharmacy Label
Authors
William H. Shrank, MD, MSHS
Patrick P. Gleason, Pharm. D.
Claire Canning, MA
Carol Walters, MBA
Alan H. Heaton, Pharm. D.
Saira Jan, Pharm. D.
Amanda Patrick, MS
M. Alan Brookhart, PhD
Sebastian Schneeweiss, MD ScD
Daniel H. Solomon, MD MPH
Jerry Avorn, MD
Niteesh K. Choudhry, MD PhD
Publication date
01-05-2009
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 5/2009
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-009-0924-x

Other articles of this Issue 5/2009

Journal of General Internal Medicine 5/2009 Go to the issue

Reflection

Stuck

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.